Completed

Trial ID CA194-010 | NCT01413906

Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors

This clinical trial is now complete. When available, results will be posted on ClinicalTrials.gov

You may check to see if you are a potential match for another clinical trial by clicking on 'Check if you qualify' button

Check if you qualify

Overview

The purpose of this study is to evaluate the tolerability and safety profile of BMS-833923 (XL139) when orally administered on a once daily schedule.